IV Ketamine Therapy in Grapevine, TX
For Grapevine residents exploring Spravato or IV ketamine, NeuroGlow offers convenient access through our Fort Worth or Flower Mound clinic, each approximately 20 minutes away. We regularly serve patients from Grapevine and across DFW, and many choose the location that fits them best after conventional treatment has not produced enough relief or meaningful improvement.
Trusted by 1000+ Patients
Breakthrough Mental Health Treatment Serving Grapevine
For patients still struggling after conventional treatment, NeuroGlow offers ketamine-based therapies designed to move faster and work differently. Our board-certified psychiatrist personally reviews every case, and our care coordinators manage insurance verification, prior authorization, and scheduling from beginning to end. That gives patients both medical oversight and practical support throughout the treatment process.
We provide Spravato (esketamine), FDA-approved for treatment-resistant depression and covered by many major insurance plans, as well as IV ketamine infusion therapy for depression, PTSD, anxiety, and chronic pain. Both treatments work on NMDA glutamate receptors and may help patients feel improvement within hours instead of weeks. For patients who have already tried multiple standard options without enough relief, that different mechanism can offer a meaningful next step.
How Far Is NeuroGlow from Grapevine?
NeuroGlow’s nearest clinic to Grapevine is our Fort Worth or Flower Mound location, approximately 20 minutes from most Grapevine addresses. We regularly serve patients from Grapevine and the surrounding area, giving you flexibility in choosing the location that works best. That added convenience can make it easier to begin care and stay consistent with a recommended treatment schedule.
If you’re coming for a Spravato session, remember that you cannot drive until the next day after your appointment and will need a designated driver or rideshare. Our care coordinators can help you plan the logistics of your first visit, including scheduling, transportation, and what to expect on treatment day. Call us at 469-218-4410 if you have questions before booking.
Spravato in Grapevine
Spravato is the only FDA-approved treatment specifically for treatment-resistant depression. Because it has FDA approval, many major insurance plans cover Spravato for eligible patients, including BCBS, Aetna, Cigna, and UnitedHealthcare. That FDA-approved status is one of the main reasons Spravato is often the most practical starting point when insurance coverage is an important factor.
Our care team verifies your Grapevine-area insurance plan for free before your first appointment and manages prior authorization from beginning to end. We help simplify the steps required before treatment can start, so you have a clearer picture of coverage and expected cost before your first session is scheduled. Most Grapevine patients pay only their standard psychiatric co-pay per session.
IV Ketamine Therapy for Grapevine
IV ketamine infusion therapy is available to Grapevine patients as a self-pay option starting at approximately $3,500 for a six-infusion induction series. Unlike Spravato, IV ketamine is administered intravenously over 40–60 minutes and is considered off-label for psychiatric use. Because it does not depend on the same insurance approval process, it can offer a more direct path to treatment for some patients.
IV ketamine may be a better fit than Spravato if your insurance does not cover Spravato, if you have chronic pain conditions alongside depression, or if a shorter infusion session works better for your schedule. It also provides another route for patients who need treatment without waiting on coverage decisions. Our clinical team will discuss both options and help you decide during your free consultation.
Conditions We Treat
At NeuroGlow, Grapevine patients can explore treatment options for conditions related to both mental health and pain management.
- Mental health: treatment-resistant depression, major depressive disorder (MDD), MDD with suicidal ideation (MDD-SI), PTSD, anxiety disorders, bipolar depression, postpartum depression, OCD, and addiction.
- Pain management: complex regional pain syndrome (CRPS), fibromyalgia, chronic migraines, neuropathic pain, phantom limb pain, and trigeminal neuralgia.
If your condition is not listed below, contact us at 469-218-4410. Our team looks at each case individually.
Why Grapevine Residents Choose NeuroGlow
- Board-certified psychiatrist involvement on every case
- Three DFW clinic locations with flexible scheduling options
- Insurance verification and prior authorization managed for you
- Private treatment rooms with a calm, clinical feel
- PHQ-9 tracking so your progress is reflected in real outcomes
- A Hero Discount for veterans, military, first responders, teachers, and healthcare workers
Spravato and Ketamine Therapy for Grapevine Residents
Grapevine residents have the shortest drive of any major DFW suburb to NeuroGlow's Flower Mound clinic at 4961 Long Prairie Rd, with most addresses inside a six to ten mile radius. For the city's approximately 55,000 residents and the broader Grapevine-Colleyville-Southlake corridor, this is the closest NeuroGlow location and the most efficient option for ongoing Spravato or IV ketamine therapy.
Why Grapevine Patients Choose Our Flower Mound Location
Grapevine sits at the convergence of DFW Airport, Lake Grapevine, and Highway 121, which means residents are well-positioned to reach our Flower Mound clinic in under fifteen minutes without using interstate highways. The Historic Main Street district, Grapevine Mills area, and the lake communities each have direct routes via William D. Tate Avenue, Northwest Highway, and FM 2499.
Patients commonly come to NeuroGlow after exhausting two or three antidepressant trials with their primary psychiatrist. Spravato is FDA-approved specifically for this scenario (treatment-resistant depression) and requires REMS certification to administer, which only a small number of clinics in the DFW area can offer. Our Flower Mound location is the closest REMS-certified provider for Grapevine.
Getting to NeuroGlow Flower Mound from Grapevine
From Grapevine, take Highway 121 north to the FM 2499 exit, then north on Long Prairie Road. From Northwest Highway (114), head east to Long Prairie Road and turn north. The clinic is just past Cross Timbers Road on the right, with free parking in front of Suite 110.
Spravato and IV Ketamine Availability
Our Flower Mound clinic is REMS-certified for Spravato (esketamine), the FDA-approved nasal spray treatment for treatment-resistant depression. IV ketamine infusions are also available for self-pay patients and for treatment plans that call for ketamine infusion therapy. Spravato coverage is accepted under BCBS of Texas, UnitedHealthcare, Aetna, Cigna, Humana, Ambetter, Curative, Texas Medicare, and TriWest.
Frequently Asked Questions from Grapevine Patients
What insurance plans cover Spravato for Grapevine residents?
Most major commercial insurance plans cover Spravato when a patient meets the FDA criteria for treatment-resistant depression. We commonly bill BCBS of Texas, UnitedHealthcare, Aetna, Cigna, and Humana. Our team handles prior authorization with each insurer before treatment begins.
Can I receive Spravato at the Flower Mound clinic while continuing to see my primary psychiatrist in Grapevine?
Yes. Many Grapevine patients keep their existing psychiatrist for medication management and add NeuroGlow specifically for Spravato or IV ketamine administration. Our medical team coordinates with outside providers on dosing schedules and treatment notes.
The first step is a free 30-minute phone or video consultation with our care coordinator. We’ll review your history, explain your options, verify your insurance coverage for Spravato, and give you a better understanding of what treatment may involve, what the next steps are, and what it may cost. No commitment is required. To book, call 469-218-4410 or use the booking button above. We see patients from Grapevine at our Fort Worth or Flower Mound clinic, and most patients begin treatment within one week of their consultation.